Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery DiseaseArterial Occlusive Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, familial hypercholesterolemia, heart disorder, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease, myocardial ischemia, vascular disorderRecruitingPhase 12026-09-02NCT06164730

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Verve Therapeutics, Inc.4

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Clinical Study CenterMelbourneAustralia3
Clinical Study CenterManchesterUnited Kingdom2
Clinical Study CenterChristchurchNew Zealand2
Clinical Study CenterTorontoCanada2
Clinical Study CenterChicoutimiCanada2
Clinical Study CenterCambridgeUnited Kingdom2
Clinical Study CenterLondonUnited Kingdom6
Clinical Study CenterBoca RatonUnited States1
Clinical Study CenterPomonaUnited States1
Clinical Study CenterAdelaideAustralia3
Clinical Study CenterDeSotoUnited States1
Clinical Study CenterPhiladelphiaUnited States1
Clinical Study CenterEdinburghUnited Kingdom1
Clinical Study CenterNottinghamUnited Kingdom2
Clinical Study CenterVancouverCanada1
Clinical Study CenterDothanUnited States1
Clinical Study CenterRentonUnited States1
Clinical Study CenterSydneyAustralia1
Clinical Study CenterHigh PointUnited States1
Clinical Study CenterHamiltonCanada1
Clinical Study CenterBirminghamUnited Kingdom2
Clinical Study CenterJacksonvilleUnited States1
Clinical Study CenterRehovotIsrael1
Clinical Study CenterMontrealCanada2
Clinical Study CenterQuébecCanada1